NOVELTOR
LIVE

Serial Number

99545582

Owner

IPSEN BIOPHARM LIMITED

Attorney

Makiko Coffland

Filing Date

Dec 12, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NOVELTOR Trademark

Serial Number: 99545582

NOVELTOR is a trademark filed by IPSEN BIOPHARM LIMITED on December 12, 2025. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

IPSEN BIOPHARM LIMITED (67 trademarks)

ASH ROAD
WREXHAM LL13 9UF , GB

Entity Type: 03

Trademark Details

Filing Date

December 12, 2025

Registration Date

Not Registered

Published for Opposition

August 4, 2026

Goods & Services

Downloadable computer software for scientific analysis within the medical field; computer hardware; downloadable data processing computer software; Computer hardware and recorded software systems for data processing

Cosmetic preparations; non-medicated skincare preparations

Chemicals for use in the pharmaceutical industry; Biological preparations for use in industry

Pharmaceutical compounding services; dispensing of pharmaceuticals; medical services; healthcare services, namely, Internet-based health care information services, consultancy services relating to health care, advisory services relating to health care; providing medical information; consultancy and information services relating to the medical effects of pharmaceutical products

Pharmaceutical preparations for use in the diagnosis, treatment, or prevention of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain; pharmaceutical preparations for aesthetic and therapeutic use, including for the diagnosis, treatment, or prevention of glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for skin care

Custom manufacture of pharmaceuticals

Medical apparatus and instruments, namely, syringes for injections, injection device for pharmaceuticals, drug delivery devices sold empty for medical or aesthetic use, namely, syringes, infusion sets, needle-based and needle-free injection systems, patches

Scientific and technological services, namely, scientific research, analysis, testing, and diagnosis for the treatment or prevention of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin, skin care; scientific research and development; medical research; design and development of computer hardware and software; product design and development in the fields of pharmaceuticals, cosmetics, and medical devices; pharmaceutical products development; testing of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others; Medical research laboratory services; providing online, non-downloadable software for scientific analysis within the medical field; consultancy and information services relating to the scientific formulation of pharmaceutical products; pharmaceutical research services

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 4, 2026 NPUB
PUBLISHED FOR OPPOSITION
Aug 4, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 29, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 8, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 8, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 8, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 31, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 12, 2025 MAFR
NEW APPLICATION ENTERED
Dec 12, 2025 NWAP